Bjoern Steffen
0009-0002-6693-4079
2 papers found
Refreshing results…
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
Missing publications? Search for publications with a matching author name.